Stroke diagnosis software e-Stroke

medicalCTvisualization

The Brainomix 360 Stroke stroke platform is a CE-marked and FDA-cleared collection of tools that use our state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time. Our proprietary software can uniquely generate critical information from simple brain scans that can help expand patient access to life-saving stroke treatments by advancing the value of simple imaging. Expanding Access to Life-Saving Treatments The largest prospective evaluation of stroke AI imaging was presented at the European Stroke Organisation Conference (ESOC) in May 2024, involving more than 83,000 patients at 26 sites assessed over a 3-year period. The results showed that Brainomix 360 Stroke was associated with an additional 50% increase in the number of patients receiving mechanical thrombectomy, while also reducing door-in-door-out (DIDO) time by nearly 50 minutes. Improving Outcomes for Stroke Patients A study published in February 2024 in Frontiers in Neurology showed that the implementation of Brainomix 360 Stroke enabled a primary stroke center to treble the number of stroke patients achieving functional independence (mRS 0-2 @ 90 days), jumping from 16% to 48%. The center also observed a 61-minute reduction in their door-in-door-out (DIDO) time. Transforming Your Stroke Network Solutions across the full stroke pathway e-ASPECTS can detect and measure both Large Vessel Occlusion (LVO) and hyperdense volumes (which may indicate bleeding), automatically assess ASPECTS score